The results of the European research project Medolution (Medical Care Evolution) will be presented at the symposium Perspective Telemedicine at Hanover Medical School on 13 March 2019.
Medolution focuses on the development of telemonitoring systems for artificial hearts. An intelligent management of the complex structure of sensor technology, network, big data, systems and cloud shall reliably monitor the functionality of the artificial heart. Part of the task is the compilation of the necessary system administration services, fault tolerance procedures and security mechanisms.
Medolution's goal is to reduce the costs of healthcare while improving the patients' quality of life.
- Dealing with huge heterogeneous datasets
Doctors and patients receive targeted notifications and warnings about relevant conditions at an early stage and are thus proactively supported in their decisions.
- Integration and combination of these data
Physicians are supported in making health-related predictions on the basis of continuous trend analyses.
- Safety and reliability in the patient's environment
It is provided to exchange health-relevant information reliably and sensitively between devices and persons.
Big data analyses can significantly accelerate medical progress when artificial hearts are used. In the so-called Big Dependable System (BDS), networked non-reliable components should now be able to make defined contributions to critical functions. A sustainable aftercare, treatment and emergency concept for patients with cardiac support systems enables patients to return to "normal" everyday life without fear and with a good quality of life.
Artificial Heart Monitoring
The Institute for Cardiovascular Research at the Schüchtermann-Klinik Bad Rothenfelde explains the German part of the Medolution project:
“The lack of donor hearts has meant that many patients with severe heart failure on the waiting list have no prospect of an appropriate donor organ. Due to the enormous technical development and miniaturization of left ventricular assist devices (LVADs) - colloquially also called artificial hearts - the implantation of these systems has become the only alternative to heart transplantation over time.
In order to provide these patients with adequate and sufficient medical monitoring to avoid life-threatening complications not only during their hospital stay but also at home, Medolution's German subproject plans to develop and test a comprehensive IT-supported telemonitoring and telemanagement system for LVAD patients."
At the symposium, various installations for patient monitoring, automated data analysis and targeted notification will demonstrate the topic of reliability:
- LVAD (artificial heart) simulator with telemedical monitoring
- Management of telemonitoring devices
- Cloud-based data analysis and alerting
- Anonymization of medical data
More About the Medolution Project
ITEA3-funded project Medolution
tetronik - Medolution (available only in German)
Information about the Symposium
Location: Foyer of the Clinical Research Center (CRC) – at the Hannover Medical School, Feodor-Lynen-Str. 15, 30625 Hannover
Time: 04:00 - 07:00 pm
- Measure Your Commitment to a Healthier Lifestyle; Dr. Anil Sinaci, SRDC
- Automating Activity Recognition with Sensors; Prof. Abdelghani Chibani, UPEC
- Making Health Data, Privacy, Anonymization work together for Research; Lora Kushner, Norima Consulting
- Chatbots in Tele-Medical Care; Dr. Wolfgang Thronicke, Atos Information Technology GmbH
- Medical Protocol Management for Telemedicine Practice; Dr. Collin Tattersall, Sopheon
- Applying Machine Learning for Remote Image-Based Infection Recognition; Dr. Rolf Neubert, Target Holding
The speakers and the Medolution team will be available for discussions and demonstrations after the presentations.
Dr. Wolfgang Thronicke, Atos Information Technology GmbH
Peter Euler, marketing tetronik GmbH
Alsakati Zeinab, registration and contact person for the symposium